Clorox Co. (CLX) financials: revenue, earnings and cash flow
Fiscal 2017–2026 + TTM · from SEC filings · data as of November 13, 2026
Summary
Clorox’s revenue went from $6.0B in fiscal 2017 to $6.7B in fiscal 2026, growth of about 1.3% a year.
Net income in fiscal 2026 was $587M, a net margin of 8.7%; the best year in this period was 2020 with $939M.
Over the twelve months to September 30, 2026, revenue was $7.2B and net income $677M.
Free cash flow was $405M in fiscal 2026 and positive in 10 of the 10 years shown.
The diluted share count fell 7% over the period (buybacks).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.2B | $6.7B | $7.1B | $7.1B | $7.4B | $7.1B | $7.3B | $6.7B | $6.2B | $6.1B | $6.0B |
| Gross profit | — | — | $3.2B | $3.0B | $2.9B | $2.5B | $3.2B | $3.1B | $2.7B | $2.7B | $2.7B |
| Operating income | — | — | $1.2B | $488M | $328M | $713M | $999M | $1.3B | $1.1B | $1.1B | $1.1B |
| Net income | $677M | $587M | $810M | $280M | $149M | $462M | $710M | $939M | $820M | $823M | $701M |
| EPS (diluted) | $5.55 | $4.81 | $6.52 | $2.25 | $1.20 | $3.73 | $5.58 | $7.36 | $6.32 | $6.26 | $5.33 |
| R&D | — | — | $121M | $126M | $138M | $132M | $149M | $145M | $136M | $132M | $135M |
| Revenue growth | — | −5.4% | +0.2% | −4.0% | +4.0% | −3.2% | +9.2% | +8.2% | +1.5% | +2.5% | +3.7% |
Cash flow
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $662M | $612M | $981M | $695M | $1.2B | $786M | $1.3B | $1.5B | $992M | $976M | $865M |
| Capital spending | -$209M | -$207M | -$220M | -$212M | -$228M | -$251M | -$331M | -$254M | -$206M | -$194M | -$231M |
| Free cash flow | $453M | $405M | $761M | $483M | $930M | $535M | $945M | $1.3B | $786M | $782M | $634M |
| Dividends paid | $602M | $602M | $602M | $595M | $583M | $571M | $558M | $533M | $490M | $450M | $412M |
| Buybacks | — | — | $332M | $0 | $0 | $25M | $905M | $248M | $661M | $271M | $183M |
| Stock-based pay | — | — | $81M | $74M | $73M | $52M | $50M | $50M | $43M | $53M | $51M |
Balance sheet
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $167M | $167M | $202M | $367M | $183M | $319M | $871M | $111M | $131M | $418M |
| Debt | — | $2.9B | $2.9B | $2.9B | $2.9B | $2.9B | $3.2B | $3.1B | $2.3B | $2.3B | $1.8B |
| Equity | — | $321M | $321M | $328M | $220M | $556M | $411M | $908M | $559M | $726M | $542M |
| Total assets | — | $5.6B | $5.6B | $5.8B | $5.9B | $6.2B | $6.3B | $6.2B | $5.1B | $5.1B | $4.6B |
| Shares (diluted) | 122M | 122M | 124M | 125M | 124M | 124M | 127M | 128M | 130M | 132M | 132M |
Margins and returns
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | 45.2% | 43.0% | 39.4% | 35.8% | 43.6% | 45.6% | 43.9% | 43.7% | 44.7% |
| Operating margin | — | — | 16.4% | 6.9% | 4.4% | 10.0% | 13.6% | 19.1% | 18.0% | 18.6% | 18.8% |
| Net margin | 9.4% | 8.7% | 11.4% | 4.0% | 2.0% | 6.5% | 9.7% | 14.0% | 13.2% | 13.4% | 11.7% |
| FCF margin | 6.3% | 6.0% | 10.7% | 6.8% | 12.6% | 7.5% | 12.9% | 19.2% | 12.7% | 12.8% | 10.6% |
| ROIC | — | — | 27.9% | 11.1% | 7.2% | 16.2% | 22.3% | 25.2% | 31.5% | 29.5% | 32.7% |
| ROE | — | — | 252.3% | 85.4% | 67.7% | 83.1% | 172.8% | 103.4% | 146.7% | 113.4% | 129.3% |
Frequently asked questions
What is Clorox’s annual revenue?
$6.7B in fiscal 2026 and $7.2B over the twelve months to September 30, 2026.
How much profit does Clorox make?
Net income was $587M in fiscal 2026 (net margin 8.7%).
Is Clorox’s revenue growing?
No: revenue fell 5.4% in fiscal 2026 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.